Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pfizer and Palbociclib in China: Analyzing an Oncology Pay-for-Performance Plan.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pfizer and Palbociclib in China: Analyzing an Oncology Pay-for-Performance Plan.
Pfizer and Palbociclib in China: Analyzing an Oncology Pay-for-Performance Plan. Value Health Reg Issues. 2022 Sep; 31:34-38.
View in:
PubMed
subject areas
Breast Neoplasms
Female
Humans
Piperazines
Pyridines
Reimbursement, Incentive
authors with profiles
Mark J. Ratain